BR112022010174A2 - Composições para aperfeiçoamento do desempenho atlético e métodos de uso das mesmas - Google Patents
Composições para aperfeiçoamento do desempenho atlético e métodos de uso das mesmasInfo
- Publication number
- BR112022010174A2 BR112022010174A2 BR112022010174A BR112022010174A BR112022010174A2 BR 112022010174 A2 BR112022010174 A2 BR 112022010174A2 BR 112022010174 A BR112022010174 A BR 112022010174A BR 112022010174 A BR112022010174 A BR 112022010174A BR 112022010174 A2 BR112022010174 A2 BR 112022010174A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- strains
- methods
- athletic performance
- improving athletic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000037147 athletic performance Effects 0.000 title abstract 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 2
- 241001331543 Veillonella sp. Species 0.000 abstract 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000131482 Bifidobacterium sp. Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000186610 Lactobacillus sp. Species 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPOSIÇÕES PARA APERFEIÇOAMENTO DO DESEMPENHO ATLÉTICO E MÉTODOS DE USO DAS MESMAS. A presente invenção refere-se a cepas microbianas, tais como cepas de Veillonella sp., e composições compreendendo as cepas que são capazes de converter lactato em propionato e acetato. A invenção também provê composições compreendendo as cepas de Veillonella sp. e bactérias produtoras de lactato, tais como cepas de Lactobacillus sp. e cepas de Bifidobacterium sp. A invenção provê ainda métodos de aperfeiçoamento do desempenho atlético, aumento da resistência a exercícios e redução de inflamação em indivíduo quando da administração das cepas ou composições reveladas.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962939793P | 2019-11-25 | 2019-11-25 | |
| US202062989226P | 2020-03-13 | 2020-03-13 | |
| US202063018697P | 2020-05-01 | 2020-05-01 | |
| PCT/US2020/062336 WO2021108643A1 (en) | 2019-11-25 | 2020-11-25 | Compositions for improving athletic performance and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022010174A2 true BR112022010174A2 (pt) | 2022-08-09 |
Family
ID=76129959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022010174A BR112022010174A2 (pt) | 2019-11-25 | 2020-11-25 | Composições para aperfeiçoamento do desempenho atlético e métodos de uso das mesmas |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220403324A1 (pt) |
| EP (1) | EP4065145A1 (pt) |
| CN (1) | CN115666605A (pt) |
| AU (1) | AU2020394447A1 (pt) |
| BR (1) | BR112022010174A2 (pt) |
| CA (1) | CA3162897A1 (pt) |
| WO (1) | WO2021108643A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109310715A (zh) | 2016-04-11 | 2019-02-05 | 哈佛学院董事及会员团体 | 用于促进运动表现的益生菌制剂 |
| WO2023098964A1 (es) * | 2021-12-01 | 2023-06-08 | Jimenez Meza Martin Francisco | Compuesto de propionato pectinato de cromo, para administrarlo vía oral y sea absorbido en el intestino grueso, para el mejoramiento en el rendimiento deportivo y contra el síndrome metabólico |
| WO2024102421A2 (en) | 2022-11-09 | 2024-05-16 | Revolution Medicines, Inc. | Compounds, complexes, and methods for their preparation and of their use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5504485B2 (ja) * | 2008-12-04 | 2014-05-28 | 国立大学法人広島大学 | Ｉｌ−８阻害剤およびその製造方法 |
| CN102971413B (zh) * | 2010-03-19 | 2014-11-26 | 株式会社益力多本社 | 属于植物乳杆菌的乳酸菌及其应用 |
| US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| US10471109B2 (en) * | 2013-05-04 | 2019-11-12 | The Board Of Regents Of The University Of Texas System | Compositions and methods for promoting nitric oxide production through an oral delivery system |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| WO2016141454A1 (en) * | 2015-03-12 | 2016-09-15 | The University Of British Columbia | Bacterial compositions and methods of use thereof |
| CN109310715A (zh) * | 2016-04-11 | 2019-02-05 | 哈佛学院董事及会员团体 | 用于促进运动表现的益生菌制剂 |
| CN111432825A (zh) * | 2017-10-03 | 2020-07-17 | 赛里斯治疗公司 | 色胺代谢的操纵 |
| EP3703720A1 (en) * | 2017-10-30 | 2020-09-09 | Seres Therapeutics, Inc. | Compositions and methods for treating antibiotic resistance |
| US20220054559A1 (en) * | 2019-02-21 | 2022-02-24 | President And Fellows Of Harvard College | Compositions and methods for enhancing exercise endurance |
-
2020
- 2020-11-25 EP EP20893225.1A patent/EP4065145A1/en active Pending
- 2020-11-25 US US17/779,676 patent/US20220403324A1/en active Pending
- 2020-11-25 CA CA3162897A patent/CA3162897A1/en active Pending
- 2020-11-25 BR BR112022010174A patent/BR112022010174A2/pt unknown
- 2020-11-25 CN CN202080093928.2A patent/CN115666605A/zh active Pending
- 2020-11-25 WO PCT/US2020/062336 patent/WO2021108643A1/en unknown
- 2020-11-25 AU AU2020394447A patent/AU2020394447A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020394447A1 (en) | 2022-07-14 |
| CN115666605A (zh) | 2023-01-31 |
| CA3162897A1 (en) | 2021-06-03 |
| EP4065145A1 (en) | 2022-10-05 |
| US20220403324A1 (en) | 2022-12-22 |
| WO2021108643A1 (en) | 2021-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022010174A2 (pt) | Composições para aperfeiçoamento do desempenho atlético e métodos de uso das mesmas | |
| BR112013011263A2 (pt) | "composição nematicida, e método para controlar nematódeos" | |
| BR112018077266A2 (pt) | composições compreendendo cepas bacterianas | |
| MY202018A (en) | Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies | |
| CL2021002602A1 (es) | Células microbianas, métodos para producir las mismas, y usos de las mismas (divisional de la solicitud no. 201902135) | |
| PH12015502416A1 (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
| WO2019066577A3 (ko) | 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물 | |
| AU2019268177A1 (en) | Improving resistance to skeletal muscle fatigue | |
| BR112017008726A2 (pt) | usos de um extrato de fermento e de um exopolissacarídeo, e, composição cosmética. | |
| MX2019009132A (es) | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. | |
| BR112018008312A2 (pt) | cepas, composição, e, kit | |
| MX2019010757A (es) | Métodos y composiciones relacionados con el tratamiento combinado con antiinflamatorios y nanoportadores sintéticos que comprenden un inmunosupresor. | |
| EP4241844A3 (en) | Compositions for topical treatment of microbial infections | |
| BR112016000072A2 (pt) | composições orais | |
| WO2012003474A3 (en) | Compositions and methods related to protein a (spa) variants | |
| BR112014019623A8 (pt) | Composição aditiva de condicionamento para o fornecimento benefícios de longa duração e imediatos para substratos de queratina | |
| PH12020550941A1 (en) | Methods and compositions to prevent microbial infection | |
| AR101072A1 (es) | Extracto de fermento de una cepa bacteriana para el aumento de los niveles de adiponectina | |
| BR112012033212A2 (pt) | uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica | |
| MX2020013064A (es) | Lactobacillus plantarum para el cuidado de la piel. | |
| WO2019067405A3 (en) | FORMULATION OF FENFLURAMINE COMPATIBLE WITH A CÉTOGENEOUS REGIMEN | |
| BR112016006048A8 (pt) | composições antimicrobianas | |
| BR112012019997A2 (pt) | composições de cuidado oral | |
| NO20082636L (no) | Anvendelse av DHA og ARA for fremstilling av en sammensetning for forebygging eller behandling av fedme | |
| WO2014127351A3 (en) | Compositions and methods to alter gut microbial fermentation using sulfate-reducing bacteria |